HIT Director Timothy Hayes reports 28,159 share disposition, 5,730 grant

Rhea-AI Filing Summary

Insider transactions by Director Timothy Hayes at Health In Tech, Inc. (HIT)

Director Timothy Hayes reported a disposition and a later acquisition of Class A common stock. On 10/03/2025 he disposed of 28,159 restricted shares that were forfeitable pro rata at the issuer's annual meeting, leaving 100,315 shares beneficially owned. On 10/08/2025 he acquired 5,730 restricted shares at a purchase price of $3.49 per share; those newly granted restricted shares vest quarterly from the grant date subject to continued service. The filing shows Hayes remains a significant insider and that his post-transaction holdings total 106,045 shares, combining previously owned and newly granted restricted stock.

Positive

• Continued insider alignment: reporting person retains 106,045 shares after transactions, signaling material ongoing ownership
• Retention-focused compensation: 5,730 restricted shares vest quarterly, tying pay to ongoing service

Negative

• Forfeiture-related disposition: 28,159 restricted shares were disposed due to forfeiture rules at the annual meeting, temporarily reducing contingent holdings
• Potential near-term dilution: new restricted grants increase outstanding beneficial holdings to 106,045

Insights

Corporate Governance Analyst

Director executed a planned disposal tied to forfeiture rules and received new restricted grants that vest over time.

The disposition of 28,159 restricted shares on 10/03/2025 was tied to forfeiture provisions that lapsed at the company's annual meeting, which reduced contingent holdings rather than an outright open-market sale. The later grant of 5,730 restricted shares on 10/08/2025 at $3.49 vests quarterly and requires continuous service, aligning compensation with retention goals.

Governance risks include concentration of insider ownership and timing of grants around corporate events; monitor vesting schedule and any future open-market trades over the next 12 months to assess dilution and insider alignment with shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hayes Timothy

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/03/2025		D		28,159(1)	D	$0	100,315	D
Class A Common Stock	10/08/2025		A		5,730(2)	A	$3.49	106,045(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.

2. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

3. Includes 5,730 shares of restricted stock and 100,315 shares of Class A Common Stock.

	By Timothy Hayes /s/ Timothy Hayes	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Health In Tech insider Timothy Hayes report on Form 4 (HIT)?

He reported a disposition of 28,159 restricted shares on 10/03/2025 and an acquisition of 5,730 restricted shares on 10/08/2025 at $3.49 per share.

How many shares does Timothy Hayes beneficially own after these transactions (HIT)?

The filing shows he beneficially owns 106,045 shares following the reported transactions (including restricted shares).

Why were 28,159 shares disposed on 10/03/2025?

Those 28,159 shares represented restricted shares that were subject to pro-rata forfeiture upon the issuer's annual stockholders meeting held on 10/03/2025.

Do the newly acquired 5,730 shares vest immediately (HIT)?

No; the 5,730 restricted shares vest quarterly commencing on the grant date and require the reporting person's continuous service through each vesting date.

Was the October activity a market sale or compensation-related change?

The October 10/03/2025 disposition was tied to forfeiture conditions from restricted grants, while the 10/08/2025 activity reflects a restricted stock grant under the equity incentive plan.